Cyclosporine vs Durvalumab
Cyclosporine vs Durvalumab: Overview
This comparison examines the pharmacological differences between Cyclosporine and Durvalumab.
Mechanism of Action
Cyclosporine: Calcineurin inhibitor suppressing T-cell activation.
Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.
Pharmacokinetics
Half-life: Cyclosporine — 6-12 hours; Durvalumab — 17 days.
Chemical Properties
Molecular Formula: Cyclosporine — C62H111N11O12.
Molecular Weight: Cyclosporine — 1202.6100 g/mol.
Type: Cyclosporine — Protein; Durvalumab — Antibody.